In conclusion, the absence of IDO1 does not affect disease in neither a CFA-elicited mouse model for sJIA, a TLR9-triggered MAS model, an MCMV-associated sHLH model, nor in mice with anti-CD3-elicited cytokine release syndrome. The gene discussed is IDO1; the disease is macrophage activation syndrome.